ClinicalTrials.Veeva

Menu

A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick

S

Seventh Sense Biosystems

Status

Unknown

Conditions

Diabetes

Treatments

Device: Fingerstick
Device: TAP20-C

Study type

Interventional

Funder types

Industry

Identifiers

NCT02045758
14-P002

Details and patient eligibility

About

This study will compare blood collection from the forearm using an investigational device TAP20-C to blood collection from the fingertip.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy Subject Group

    1. Male and female volunteers 18 years of age or older.
    2. Voluntary written consent to participate in this study. Diabetic Subject Group
    <!-- -->
    1. Male and female volunteers 18 years of age or older.
    2. Have been diagnosed with Type 1 or Type 2 diabetes mellitus by self-report.
    3. Voluntary written consent to participate in this study.

Exclusion criteria

  1. Subjects who are pregnant or nursing mothers by self-report.
  2. Subjects with a history of skin disorders or who present with abnormal skin integrity or atypical skin health within the areas to be tested.
  3. Subjects with a missing index or middle finger on either hand or a missing forearm
  4. Subjects who have known allergies to titanium.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 2 patient groups

TAP20-C
Experimental group
Description:
TAP20-C
Treatment:
Device: TAP20-C
Fingerstick
Active Comparator group
Description:
Fingerstick
Treatment:
Device: Fingerstick

Trial contacts and locations

1

Loading...

Central trial contact

Howard Bernstein, MD, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems